United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2013_register executive 2013-02-28 article Notices D09002ee1c7fbcc4e D09002ee1c7fbcce3 United States Department of Health and Human Services originator org United States Government Agency or Subagency United States National Institutes of Health originator org United States Government Agency or Subagency This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive license to practice the inventions embodied in (a) U.S. Patent Application 61/717,960 entitled "M971 Chimeric Antigen Receptors" [HHS Ref. E-291-2012/0-US-01], and (b) U.S. Patent Application 61/042,239 entitled "Human Monoclonal Antibodies Specific for CD22" [HHS Ref. E-080-2008/0-US-01], PCT Application PCT/US2009/ 124109 entitled "Human and Improved Murine Monoclonal Antibodies Against CD22" [HHS Ref. E-080-2008/0-PCT-02], US patent application 12/934,214 entitled "Human Monoclonal Antibodies Specific for CD22 " [HHS Ref. E-080-2008/0-US-03], and all related continuing and foreign patents/patent applications for these technology families, to Neomune, Inc. The patent rights in these inventions have been assigned to and/or exclusively licensed to the Government of the United States of America. The prospective exclusive license territory may be worldwide, and the field of use may be limited to: 78 FR 13691 https://www.govinfo.gov/app/details/FR-2013-02-28/2013-04585 2013-04585 fr28fe13-104 4140-01-P https://www.govinfo.gov/app/details/FR-2013-02-28/2013-04585 https://www.govinfo.gov/content/pkg/FR-2013-02-28/html/2013-04585.htm https://www.govinfo.gov/content/pkg/FR-2013-02-28/pdf/2013-04585.pdf 1 p. 13691 13691 78 FR 13691 Prospective Grant of Exclusive License: The Development of m971 and m972 Chimeric Antigen Receptors (CARs) for the Treatment of B Cell Malignancies; Federal Register Vol. 78, Issue NOTICE 2013-04585 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health 2013-04-01 4140-01-P 2013-04585 Notice.

This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive license to practice the inventions embodied in (a) U.S. Patent Application 61/717,960 entitled "M971 Chimeric Antigen Receptors" [HHS Ref. E-291-2012/0-US-01], and (b) U.S. Patent Application 61/042,239 entitled "Human Monoclonal Antibodies Specific for CD22" [HHS Ref. E-080-2008/0-US-01], PCT Application PCT/US2009/ 124109 entitled "Human and Improved Murine Monoclonal Antibodies Against CD22" [HHS Ref. E-080-2008/0-PCT-02], US patent application 12/934,214 entitled "Human Monoclonal Antibodies Specific for CD22 " [HHS Ref. E-080-2008/0-US-03], and all related continuing and foreign patents/patent applications for these technology families, to Neomune, Inc. The patent rights in these inventions have been assigned to and/or exclusively licensed to the Government of the United States of America. The prospective exclusive license territory may be worldwide, and the field of use may be limited to:

Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before April 1, 2013 will be considered. Prospective Grants of Exclusive Licenses: Development of m971 and m972 Chimeric Antigen Receptors for the Treatment of B Cell Malignancies , lambertsond@mail.nih.gov Vol. 78, no. 40 Office of the Federal Register, National Archives and Records Administration 2013-02-28 continuing daily deposited born digital 339 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2013-02-28 P0b002ee183db0b1e 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr28fe13 https://www.govinfo.gov/app/details/FR-2013-02-28 https://www.govinfo.gov/content/pkg/FR-2013-02-28/pdf/FR-2013-02-28.pdf https://www.govinfo.gov/content/pkg/FR-2013-02-28/xml/FR-2013-02-28.xml fdlp 13443 13770 DGPO 2013-02-28 2024-06-03 FR-2013-02-28 machine generated eng FR FR-2013-02-28 78 40